Microbiologist with focus on antibiotic resistant bacteria. Currently running national HCAI surveillance. Views presented on this account are my personal ones.
📣 UKHSA is asking sexual health clinics and labs across England to help build a clearer picture of gonorrhoea testing.
Take part in this survey and help contribute to future improvements in GC culture!
🔗 https://t.co/rwXuX2MNET
Really enjoyed Journal Club today about the economics and practicalities of disinfecting shared medical equipment. Loads of great audience questions! Recording here: https://t.co/lEys37StiJ
Really looking forward to this one with @juderobinson5. So much to talk about. So many opportunities to involve patients in hand hygiene: challenge, audit, communications, applied research, and more…
An important call is emerging from scientists, physicians, and patients to add C. difficile to the WHO priority list.....@ECDC_EU@rivm@NVMM_NL@EurFmt
https://t.co/vva13SM0Rj
🆕🔥 State of the art review article @CMIComms 🌟s @DrToddLee@DrEmilyMcD
Approach to Clostridioides difficile Diarrheal Infection ( CDI)
Excellent discussions about the management of CDI #IDXposts#mustread
https://t.co/dXNvlF6iDf
Invitation: submit projects focused on tackling antimicrobial resistance for the #AntibioticGuardian Shared Learning & Awards
Deadline: 10th January 2025.
Scan the QR code or visit https://t.co/zDnaNJWg1F to submit your entry. @AG_AwardsandSL
Two colleagues (including one in Australia) independently wished team and I
Happy ESPAUR Day today
So I have adopted
Thank you to all authors, contributors and #ESPAUR oversight group members
Such an invaluable collaboration within and external to @@UKHSA
11th report ✅
PUBLISHED: The 2023-24 English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report https://t.co/cyE1WCdprs
Register to find out more about the findings in the report at the webinar we are hosting on 20th November: https://t.co/PCrqcNYAfX
Drug-resistant infections know no borders 💊
That’s why tomorrow, a UN High-Level Meeting will take place to address the global issue of antimicrobial resistance (#AMR).
Explore the latest research 🧵
New data released today in @TheLancet shows that without urgent action, antimicrobial resistance could kill 39 million people by 2050.
Deaths and inequities from the global antibiotic emergency are increasing and now is the time to take urgent action.
https://t.co/O91bRl2G91
Unveiling plasmid diversity in nature
https://t.co/HrZ7S0f7C9
This Genome Watch discuses metagenomic surveys that have revealed the extensive prevalence and diversity of plasmids in the human gut microbiome, and the challenges in reporting plasmid genomes from metagenomic data.
Urinary tract infection (UTI) is one of the most common bacterial infections in the global community.
A Review in @TheLancetInfDis aims to achieve consensus on a reference standard for UTI and increase consistency between studies: https://t.co/lcnQ0Aie4x
Save the date! The ever-popular two-day virtual conference jointly organised by BSAC and @gardp_amr is taking place on 4-5 February 2025, with Fiocruz and Cepid Aries as collaborating organisations. The outline programme and abstract submission details are now available.
https://t.co/MYTOKQ65C7
Thanks for this French-Dutch-USA collaboration! FMT doesn't eradicate antibiotic resistant gram-negative bacteria, but changes the gut microbiome and possibly reduces infections. @EurFmt@SmitsLab@jvanprehn@GMFHx@HostMicrobeLit https://t.co/ci4fClDDuD
"It’s not a silent pandemic for the families and communities affected by #AMR. We must protect modern medicine for future generations or face catapulting from the 21st century to the 19th."
@RobbButler2 addressing the @EU2024BE AMR conference:
https://t.co/HYApskD9EW